论文信息 - Abstract PR11: eFT508: An oral, potent and highly selective inhibitor of MNK1 and MNK2, promotes anti-tumor immunity as a monotherapy and in combination with immune checkpoint blockade - 字舞流文

Abstract PR11: eFT508: An oral, potent and highly selective inhibitor of MNK1 and MNK2, promotes anti-tumor immunity as a monotherapy and in combination with immune checkpoint blockade

P. A. Thompson | C. Stumpf | K. Webster | Chinh Tran | G. Chiang | V. Huang | P. Sprengeler | S. Reich | V. Goel | C. Wegerski | J. Ernst | S. Sperry | Joan W Chen | J. Staunton | I. N. Hung | Jolene Molter | S. Webber | G. Parker